A new trial is aiming to reduce symptoms and improve the quality of life of young Australians with hay fever, the country’s most common allergic disease. To help tackle this chronic condition, 17 general practices and allergy clinics across Australia have partnered with the National Allergy Centre of Excellence (NACE), hosted at Murdoch Children’s Research Institute (MCRI), to launch the ARISE Trial. The clinical trial is seeking 14 to 29 year olds with hay fever, with participants to follow a specifically designed education package alongside their daily nasal spray. The trial will explore whether they experience less symptoms and have better quality of life.
Find out more